Neurologic disorders after measles-mumps-rubella vaccination

Pediatrics

Volumn 110, Issue 5, 2002, Pages 957-963

  Mäkelä, Annamari ^a   Nuorti, J Pekka ^b   Peltola, Heikki ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

Adverse effects; Aseptic meningitis; Autism; Autistic disorders; Encephalitis; Immunization; Measles; MMR vaccine; Mumps; Rubella

Indexed keywords

MEASLES MUMPS RUBELLA VACCINE;

ARTICLE; ASEPTIC MENINGITIS; AUTISM; BRAIN DISEASE; CHILD; CHILD HOSPITALIZATION; CONTROLLED STUDY; CROHN DISEASE; DRUG SAFETY; ENCEPHALITIS; ENTERITIS; HIGH RISK POPULATION; HOSPITAL DISCHARGE; HUMAN; MAJOR CLINICAL STUDY; MEASLES VACCINATION; MUMPS; NEUROLOGIC DISEASE; PRIORITY JOURNAL; RUBELLA; ULCERATIVE COLITIS; VACCINATION;

AUTISTIC DISORDER; CHILD; CHILD, HOSPITALIZED; CHILD, PRESCHOOL; ENCEPHALITIS; FINLAND; HUMANS; INFANT; MEASLES-MUMPS-RUBELLA VACCINE; MENINGITIS, ASEPTIC; NATIONAL HEALTH PROGRAMS; REGISTRIES; RETROSPECTIVE STUDIES;

EID: 0036842266     PISSN: 00314005     EISSN: None     Source Type: Journal    
DOI: 10.1542/peds.110.5.957     Document Type: Article

References (38)

1. Stratton KR, Howe CJ, Johnston RB Jr, eds. Adverse Events Associated With Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: National Academy Press; 1993
2. Peltola H, Heinonen OP, Valle M, et al. The elimination of indigenous measles, mumps, and rubella from Finland by a 12-year, two-dose vaccination program. N Engl J Med. 1994;331:1397-1402
3. World Health Organization. Measles: Progress towards global control and regional elimination, 1998-1999. Weekly Epidemiol Rec. 1999;74:429-439
4. Brooks GF, Butel JS, Morse SA. Paramyxoviruses and rubella virus. In: Butler JP, Ransom J, Ryan E, eds. Jawetz, Melnick, & Adelberg's Medical Microbiology. 21st Ed. Stamford, Conn: Appleton & Lange; 1998:507-527
5. Roos RP, Graves MC, Wollmann RL, Chilcote RR, Nixon J, Immunologic and virologic studies of measles inclusion body encephalitis in an immunosuppressed host: The relationship to subacute sclerosing panencephalitis. Neurology. 1981;31:1263-1270
6. Johnson RT, Griffin DE, Hirsch RL, et al. Measles encephalomyelitis: Clinical and immunologic studies. N Engl J Med. 1984;310:137-141
7. White CC, Koplan JP, Orenstein WA. Benefits, risks and costs of immunization for measles, mumps and rubella. Am J Public Health. 1985;75:739-744
8. Weibel RE, Caserta V, Benor DE, Evans G. Acute encephalopathy followed by permanent brain injury or death associated with further attenuated measles vaccines: A review of claims submitted to the National Vaccine Injury Compensation Program. Pediatrics. 1998;101:383-387
9. McDonald JC, Moore DL, Quennec P. Clinical and epidemiologic features of mumps meningoencephalitis and possible vaccine-related disease. Pediatr Infect Dis J. 1989;8:751-755
10. Schoenbaum SC, Hyde JN Jr, Bartoshesky L, Crampton K. Benefit-cost analysis of rubella vaccination policy. N Engl J Med. 1976;294:306-310
11. Pampiglione G, Griffith AH, Bramwell EC. Transient cerebral changes after vaccination against measles. Lancet. 1971;2:55-88
12. Crowley S, Al-Jawad ST, Kovar IZ. Mumps, measles, and rubella vaccination and encephalitis. BMJ. 1989;299:660
13. Ehrengut W. Mumps vaccine and meningitis. Lancet. 1989;2:751
14. Black S, Shinefield H, Ray P, et al. Risk of hospitalization because of aseptic meningitis after measles-mumps-rubella vaccination in one- to two-year-old children: An analysis of the Vaccine Safety Datalink (VSD) Project. Pediatr Infect Dis J. 1997;16:500-503
15. Bitnun A, Shannon P, Durward A, et al. Measles inclusion-body encephalitis caused by the vaccine strain of measles virus. Clin Infect Dis. 1999,29:855-861
16. Landrigan PJ, Witte JJ. Neurologic disorders following live measles-virus vaccination. JAMA. 1973;223:1459-1462
17. Cizman M, Mozetic M, Radescek-Rakar R, Pleterski-Rigler D, Susec-Michieli M. Aseptic meningitis after vaccination against measles and mumps. Pediatr Infect Dis J. 1989;8:302-308
18. Sugiura A, Yamada A. Aseptic meningitis as a complication of mumps vaccination. Pediatr Infect Dis J. 1991;10:209-213
19. Miller E, Goldacre M, Pugh S, et al. Risk of aseptic meningitis after measles, mumps, and rubella vaccine in UK children. Lancet. 1993;341:979-982
20. Dourado I, Cunha S, da Gloria Teixeira M, et al. Outbreak of aseptic meningitis associated with mass vaccination with a Urabe-containing measles-mumps-rubella vaccine: Implications for immunization programs. Am J Epidemiol. 2000;151:524-530
21. Anonymous. Two MMR vaccines withdrawn. Lancet. 1992;340:722
22. Wakefield AJ, Murch SH, Anthony A, et al. Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. Lancet. 1998;351:637-641
23. Wakefield AJ, Montgomery SM. Measles, mumps, rubella vaccine: Through a glass, darkly. Adverse Drug React Toxicol Rev. 2000;19:265-283
24. Paunio M. Rokotusmyöntyvyys ja Rokotuskattavuus [dissertation]. Helsinki, Finland: University of Helsinki; 1988
25. Mähönen M, Salomaa V, Brommels M, et al. The validity of hospital discharge register data on coronary heart disease in Finland. Eur J Epidemiol. 1997;13:403-415
26. Beghi E, Nicolosi A, Kurland LT, Mulder DW, Hauser WA, Shuster L. Encephalitis and aseptic meningitis, Olmsted County, Minnesota, 1950-1981: I. Epidemiology. Ann Neurol. 1984;16:283-294
27. Koskiniemi M, Vaheri A. Effect of measles, mumps, rubella vaccination on pattern of encephalitis in children. Lancet. 1989;1:31-34
28. Steffenburg S, Gillberg C, Hellgren L, et al. A twin study of autism in Denmark, Finland, Iceland, Norway and Sweden. J Child Psychol Psychiatry. 1989;30:405-416
29. Altman DG. Practical Statistics for Medical Research. 1st Ed. London, United Kingdom: Chapman & Hall; 1991:241-265
30. White F. Measles vaccine associated encephalitis in Canada. Lancet. 1983;2:683-684
31. Fujinaga T, Motegi Y, Tamura H, Kuroume T. A prefecture-wide survey of mumps meningitis associated with measles, mumps and rubella vaccine. Pediatr Infect Dis J. 1991;10:204-209
32. Schneck SA. Vaccination with measles and central nervous system disease. Neurology. 1968;18:79-82
33. Gray JA, Burns SM. Mumps vaccine meningitis. Lancet. 1989;2:927
34. Ueda K, Miyazaki C, Hidaka Y, Okada K, Kusuhara K, Kadoya R. Aseptic meningitis caused by measles-mumps-rubella vaccine in Japan. Lancet. 1995;346:701-702
35. Taylor B, Miller E, Farrington CP, et al. Autism and measles, mumps, and rubella vaccine: No epidemiological evidence for a causal association. Lancet. 1999;353:2026-2029
36. Kaye JA, del Mar Melero-Montes M, Jick H. Mumps, measles, and rubella vaccine and the incidence of autism recorded by general practitioners: A time trend analysis. BMJ. 2001;322:460-463
37. Dales L, Hammer SJ, Smith NJ. Time trends in autism and in MMR immunization coverage in California. JAMA. 2001;285:1183-1185
38. Gillberg C, Wing L. Autism: Not an extremely rare disorder. Acta Psychiatry Scand. 1999;99:399-406